JP2005538930A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005538930A5 JP2005538930A5 JP2003564087A JP2003564087A JP2005538930A5 JP 2005538930 A5 JP2005538930 A5 JP 2005538930A5 JP 2003564087 A JP2003564087 A JP 2003564087A JP 2003564087 A JP2003564087 A JP 2003564087A JP 2005538930 A5 JP2005538930 A5 JP 2005538930A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- foxc2
- seq
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001184 polypeptide Polymers 0.000 claims 32
- 102000004196 processed proteins & peptides Human genes 0.000 claims 32
- 108090000765 processed proteins & peptides Proteins 0.000 claims 32
- 102100021083 Forkhead box protein C2 Human genes 0.000 claims 25
- 101000818305 Homo sapiens Forkhead box protein C2 Proteins 0.000 claims 25
- 230000000694 effects Effects 0.000 claims 21
- 239000000126 substance Substances 0.000 claims 21
- 125000003275 alpha amino acid group Chemical group 0.000 claims 18
- 239000008194 pharmaceutical composition Substances 0.000 claims 15
- 108090000623 proteins and genes Proteins 0.000 claims 15
- 102000004169 proteins and genes Human genes 0.000 claims 15
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical group C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 8
- 238000000034 method Methods 0.000 claims 6
- 230000002265 prevention Effects 0.000 claims 6
- 230000015572 biosynthetic process Effects 0.000 claims 5
- 230000001575 pathological effect Effects 0.000 claims 5
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 4
- 108700017904 mesenchyme fork head 1 Proteins 0.000 claims 3
- 206010022489 Insulin Resistance Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 208000022531 anorexia Diseases 0.000 claims 2
- 206010061428 decreased appetite Diseases 0.000 claims 2
- 230000037213 diet Effects 0.000 claims 2
- 235000005911 diet Nutrition 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 208000006575 hypertriglyceridemia Diseases 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 239000000969 carrier Substances 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0200265A SE0200265D0 (sv) | 2002-01-29 | 2002-01-29 | Protein complexes |
| US37734902P | 2002-04-30 | 2002-04-30 | |
| PCT/SE2003/000139 WO2003064467A1 (en) | 2002-01-29 | 2003-01-28 | A complex of a human foxc2 protein and a foxc2-interacting protein |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005538930A JP2005538930A (ja) | 2005-12-22 |
| JP2005538930A5 true JP2005538930A5 (enExample) | 2006-03-16 |
Family
ID=27667646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003564087A Pending JP2005538930A (ja) | 2002-01-29 | 2003-01-28 | ヒトｆｏｘｃ２タンパク質およびｆｏｘｃ−２相互作用タンパク質の複合体 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US7217692B2 (enExample) |
| EP (1) | EP1468017A1 (enExample) |
| JP (1) | JP2005538930A (enExample) |
| WO (1) | WO2003064467A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005099363A2 (en) | 2004-03-26 | 2005-10-27 | Whitehead Institute For Biomedical Research | Methods of diagnosing, preventing and treating cancer metastasis |
| JP2008540586A (ja) * | 2005-05-18 | 2008-11-20 | フォルシュングスフェアブント ベルリン エー ファウ | Ａｋａｐ−ｐｋａ相互作用の非ペプチド阻害剤 |
| WO2008086090A1 (en) * | 2007-01-05 | 2008-07-17 | University Of Washington | Self-assembled heterogeneous integrated optical analysis system |
| US8579434B2 (en) | 2007-11-07 | 2013-11-12 | University Of Washington Through Its Center For Commercialization | Free-standing two-sided device fabrication |
| US11096901B2 (en) | 2009-03-06 | 2021-08-24 | Metaqor Llc | Dynamic bio-nanoparticle platforms |
| US11235062B2 (en) * | 2009-03-06 | 2022-02-01 | Metaqor Llc | Dynamic bio-nanoparticle elements |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9701963D0 (sv) * | 1997-05-26 | 1997-05-26 | Pharmacia & Upjohn Ab | Novel transcription factor |
| WO2001060853A1 (en) * | 2000-02-18 | 2001-08-23 | Biovitrum Ab | Transgenic animal model for obesity expressing foxc2 |
| CA2421620A1 (en) * | 2000-09-26 | 2002-04-04 | Biovitrum Ab | Promoter sequences |
-
2003
- 2003-01-28 JP JP2003564087A patent/JP2005538930A/ja active Pending
- 2003-01-28 WO PCT/SE2003/000139 patent/WO2003064467A1/en not_active Ceased
- 2003-01-28 EP EP03734938A patent/EP1468017A1/en not_active Withdrawn
- 2003-01-28 US US10/500,941 patent/US7217692B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022105138A5 (enExample) | ||
| Abramson et al. | Structure and mechanism of the lactose permease of Escherichia coli | |
| RU2000124084A (ru) | Химерное антитело, которое связывается с CD40 человека (варианты), молекула нуклеиновой кислоты (варианты), вектор экспрессии (варианты), гуманизированное антитело (варианты), фармацевтическая композиция для лечения заболевания, опосредованного Т-клетками (варианты), способ лечения больного от заболевания, опосредованного Т-клетками (варианты) | |
| Kostal et al. | Tunable biopolymers for heavy metal removal | |
| Abramson et al. | The lactose permease of Escherichia coli: overall structure, the sugar-binding site and the alternating access model for transport | |
| Arul et al. | Biotinylated GHK peptide incorporated collagenous matrix: A novel biomaterial for dermal wound healing in rats | |
| JP2012523438A5 (enExample) | ||
| JP2002516318A5 (enExample) | ||
| JP2008503217A5 (enExample) | ||
| CA2332570A1 (en) | Uses of the borreliacidal epitope(s) of borrelia burgdorferi outer surface protein c (ospc) as vaccine | |
| JP2005538930A5 (enExample) | ||
| Matilla et al. | Bacterial amino acid chemotaxis: a widespread strategy with multiple physiological and ecological roles | |
| US20150291662A1 (en) | Modified peptide, cb receptor ligand, kit in vitro process for evaluating cb receptor bonds, uses, pharmaceutical composition for modulating cb receptor activity | |
| JP2005535289A5 (enExample) | ||
| JP2005525112A5 (enExample) | ||
| JP2005528921A5 (enExample) | ||
| JP2007500005A5 (enExample) | ||
| Wu et al. | Effect of recombinant adenovirus coding for endomorphin-2 on neuropathic pain in rats | |
| RU97104072A (ru) | Модуляторы веса тела, соответствующие нуклеиновые кислоты и протеины, а также их применение для диагностических и терапевтических целей | |
| JP2005516604A5 (enExample) | ||
| JP2002518016A5 (enExample) | ||
| JP2004533848A5 (enExample) | ||
| JP2008522632A5 (enExample) | ||
| JP2005507651A5 (enExample) | ||
| JP2005522229A5 (enExample) |